Annotation Detail

Information
Associated Genes
FGFR1
Associated Variants
FGFR1 EXPRESSION
FGFR1 EXPRESSION
Associated Disease
bladder carcinoma
Source Database
CIViC Evidence
Description
One urothelial cell line (JMSU1) with high expression of FGFR1 was sensitive to treatment with FGFR inhibitors (SU5402, TKI258 or PD173074). IC50 values for PD173074 and TKI-258 (Dovitinib) were in nanomolar range compared with micromolar concentration for SU5402.
Variant Origin
N/A
Variant Origin
N/A
Evidence URL
https://civic.genome.wustl.edu/links/evidence_items/801
Gene URL
https://civic.genome.wustl.edu/links/genes/1885
Variant URL
https://civic.genome.wustl.edu/links/variants/268
Rating
2
Evidence Type
Predictive
Disease
Bladder Carcinoma
Evidence Direction
Supports
Drug
PD173074,Dovitinib
Evidence Level
D
Clinical Significance
Sensitivity/Response
Pubmed
21119661
Drugs
Drug NameSensitivitySupported
DovitinibSensitivitytrue
PD173074Sensitivitytrue